Full name
BIOLABINVEST SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.11.Z - Research and experimental development on biotechnology
20.14.Z - Manufacture of other organic basic chemicals
20.42.Z - Manufacture of perfumes and toilet preparations
20.59.Z - Manufacture of other chemical products not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
71.20.A - Food quality testing and analysis
71.20.B - Other technical testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
86.10.Z - Hospital activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -3,4 | 0,7 | -0,9 | -227,4 |
EBITDA | 0,1 | -0,8 | -1,3 | -58,8 |
Short time liabilities | 2,9 | 0,5 | 0 | -100 |
Equity capital | 35,4 | 35,1 | 34,2 | -2,5 |
Operating profit (EBIT) | -2,5 | -2 | -1,3 | 35,2 |
Assets | 66,1 | 35,6 | 34,7 | -2,7 |
Net profit (loss) | -3,4 | 0,7 | -0,9 | -227,4 |
Cash | 0 | 5,7 | 3,8 | -33,2 |
Net income from sale | 0 | 0 | 0,2 | -∞ |
Liabilities and provisions for liabilities | 30,6 | 0,5 | 0,4 | -13,6 |
Working assets | 25,5 | 27 | 24,5 | -9,2 |
Depreciation | 2,6 | 1,2 | 0 | -97,4 |
% | % | % | p.p. | |
Profitability of capital | -9,6 | 2 | -2,6 | -4,6 |
Equity capital to total assets | 53,6 | 98,6 | 98,8 | 0,2 |
Gross profit margin | -370,9 | |||
EBITDA Margin | -529,4 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 0 | -2 147 483 648 |
Current financial liquidity indicator | 8.858874320983887 | 53.94468307495117 | 45 | |
Net dept to EBITDA | 11.428244590759277 | 6.588723659515381 | 2.6587915420532227 | -3,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane